Prof. Rozita  Rosli
My Social Links

Prof. Rozita Rosli

Professor
Universiti Putra Malaysia, Malaysia


Highest Degree
PostDoc Fellow in Oncology from Indiana University School of Medicine, USA

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Molecular Biology
62%
Oncology
90%
Cancer Research
75%
Biosynthesis
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Nigjeh, S.E., S.K. Yeap, N. Nordin, B. Kamalideghan, H. Ky and R. Rosli, 2018. Citral induced apoptosis in MDA-MB-231 spheroid cells. BMC Complement. Altern. Med., Vol. 18. 10.1186/s12906-018-2115-y.
    CrossRef  |  Direct Link  |  
  2. Sayyad, M., N. Tiang, Y. Kumari, B.H. Goh and Y. Jaiswal et al., 2017. Acute toxicity profiling of the ethyl acetate fraction of Swietenia macrophylla seeds and in-vitro neuroprotection studies. Saudi Pharmaceut. J., 25: 196-205.
    CrossRef  |  Direct Link  |  
  3. Malami, I., A.B. Abdul, R. Abdullah, N.K.B. Kassim and R. Rosli et al., 2017. Crude extracts, flavokawain B and alpinetin compounds from the rhizome of Alpinia mutica induce cell death via UCK2 enzyme inhibition and in turn reduce 18S rRNA biosynthesis in HT-29 cells. PLoS ONE, Vol. 12. 10.1371/journal.pone.0170233.
    CrossRef  |  Direct Link  |  
  4. Adamu, H.A., M.U. Imam, D.J. Ooi, N.M. Esa, R. Rosli and M Ismail, 2017. In utero exposure to germinated brown rice and its oryzanol-rich extract attenuated high fat diet-induced insulin resistance in F1 generation of rats. BMC Complement. Altern. Med., Vol. 17. 10.1186/s12906-017-1571-0.
    CrossRef  |  Direct Link  |  
  5. Zamanian, M., L.A.Q. Hamadneh, A. Veerakumarasivam, S.A. Rahman, S. Shohaimi and R. Rosli, 2016. Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways. Cancer Cell Int., Vol. 16. 10.1186/s12935-016-0329-y.
    CrossRef  |  Direct Link  |  
  6. Tiong, K.H., B.S. Tan, H.L. Choo, F.F.L. Chung and L.W. Hii et al., 2016. Fibroblast Growth Factor Receptor 4 (FGFR4) and Fibroblast Growth Factor 19 (FGF19) autocrine enhance breast cancer cells survival. Oncotarget, 7: 57633-57650.
    CrossRef  |  Direct Link  |  
  7. Low, M.L., L. Maigre, M.I.M. Tahir, E.R. Tiekink and P. Dorlet et al., 2016. New insight into the structural, electrochemical and biological aspects of macroacyclic Cu(II) complexes derived from S-substituted dithiocarbazate Schiff bases. Eur. J. Med. Chem., 120: 1-12.
    CrossRef  |  Direct Link  |  
  8. Chin, F.W., S.C. Chan, S. Abdul Rahman, S.N. Akmal and R. Rosli, 2016. CYP2D6 genetic polymorphisms and phenotypes in different ethnicities of Malaysian breast cancer patients. Breast J., 22: 54-62.
    CrossRef  |  Direct Link  |  
  9. Tan, B.S., K.H. Tiong, H.L. Choo, F.F.L. Chung and L.W. Hii et al., 2015. Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-Modifying Factor (BMF). Cell Death Dis., Vol. 6. 10.1038/cddis.2015.191.
    CrossRef  |  Direct Link  |  
  10. Ghiasi, N., M. Habibagahi, R. Rosli, A. Ghaderi and K. Yusoff et al., 2015. Tumor suppressive effects of WEE1 gene silencing could not enhance immunopotentiation effects of CD80 and 4-1BBL co-stimulation in human T cells. J. Cancer Res. Therapeut., 11: 708-716.
    CrossRef  |  Direct Link  |